28 Apr 2022 07:00
Β
Intelligent Ultrasound Group plc
("Intelligent Ultrasound" or the "Group")
Β
Investor Presentation
Β
Intelligent Ultrasound Group plc (AIM: IUG), the 'classroom to clinic' ultrasound artificial intelligence (AI) software and simulation group, is pleased to announce that Stuart Gall, CEO, and Helen Jones, CFO, will provide a live presentation relating to Preliminary Results via the Investor Meet Company platform on Tuesday, 3rd May 2022 at 2:15pm BST.
Β
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.
Β
Investors can sign up to Investor Meet Company for free and add to meet Intelligent Ultrasound Group plc via: https://www.investormeetcompany.com/intelligent-ultrasound-group-plc/register-investorΒ
Β
Investors who already follow Intelligent Ultrasound Group plc on the Investor Meet Company platform will automatically be invited.
Β
For further information, please contact:
Β
Intelligent Ultrasound Group plcΒ | www.Β intelligentultrasound.com | Β | ||||||||
Stuart Gall, CEOΒ | Tel: +44 (0)29 2075 6534Β | Β | ||||||||
Β | Β | Β | ||||||||
Helen Jones, CFO | Β | Β | ||||||||
Β | Β | Β | ||||||||
Β | Β | Β | ||||||||
Cenkos SecuritiesΒ - Nominated Advisor and Broker | Tel: +44 (0)20 7397 8900Β | Β | ||||||||
Giles Balleny / Max GouldΒ (Corporate Finance) | Β | Β | ||||||||
Michael JohnsonΒ /Β Julian MorseΒ (Sales)Β | Β | Β | ||||||||
Β | Β | Β | ||||||||
Β | Β | Β | ||||||||
Β | Β | Β | ||||||||
Walbrook PRΒ | Tel: +44 (0)20 7933 8780 orΒ intelligentultrasound@walbrookpr.comΒ | Β | ||||||||
Anna DunphyΒ /Β Paul McManusΒ | Mob: +44 (0)7876 741 001Β / Mob: +44 (0)7980 541 893 | Β | ||||||||
Β | Β | Β | Β | Β | Β | |||||
| Β | Β | Β | Β | Β | Β | Β | Β | Β | Β | Β |
Β
AboutΒ Intelligent Ultrasound Group
Β
Intelligent UltrasoundΒ (AIM: IUG) is one of the world's leading 'classroom to clinic' ultrasound companies, specialising in real-time hi-fidelity virtual reality simulation for the ultrasound training market ('classroom') and artificial intelligence-basedΒ clinical image analysis software tools for the diagnostic medical ultrasound market ('clinic'). Based inΒ CardiffΒ in theΒ UKΒ andΒ AtlantaΒ in the US, the Group has two revenue streams:
Β
SimulationΒ
Β
Focusses on real-time hi-fidelity ultrasound education and training through simulation. Its main products are theΒ ScanTrainer obstetrics and gynaecology training simulator, theΒ HeartWorksΒ echocardiography training simulator, theΒ BodyWorksΒ EveΒ Point of Care and Emergency Medicine training simulator with Covid module and the new BabyWorks Neonate and Paediatric training simulator. To dateΒ over 1,350 simulators have been sold toΒ overΒ 650 medical institutions around the world.
Β
Clinical AI software
Β
Focusses on developing deep learning-based algorithms to make ultrasound machines smarter and more accessible using our proprietary ScanNav ultrasound image analysis technology. Current products on the market utilising this technology are GE Healthcare'sΒ SonoLyst software that is incorporated in their Voluson SWIFT ultrasound machine; ScanNav Anatomy PNB that simplifies ultrasound-guided needling by providing the user with real-time AI-based anatomyΒ highlighting for a range of medical procedures; and NeedleTrainer that teaches real-time ultrasound guided needling and incorporates ScanNav Anatomy PNB.Β
Β
www.intelligentultrasound.com
Β
NOTE: ScanNav Anatomy PNB is not yet available for sale in the US or any other territory requiring government approval for this type of product.
Β
Β
Β
Β
Follow the stocks